Evidence map›Paper›PMID 23983140›Full record

ArticleAdvanced healthcare materials2014

Rapid prototyping of concave microwells for the formation of 3D multicellular cancer aggregates for drug screening.

Ting-Yuan Tu, Zhe Wang, Jing Bai, Wei Sun, Weng Kung Peng, Ruby Yun-Ju Huang, Jean-Paul Thiery, Roger D Kamm

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Exploring Endothelial Expansion on a Chip.Sensors (Basel, Switzerland) · 2022
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ting-Yuan TuBioSystems and Micromechanics IRG, Singapore-MIT Alliance for Research and Technology (SMART) Center, 1 CREATE Way, #04-13/14 Enterprise, Wing, Singapore, 138602, Singapore.
Zhe Wang
Jing Bai
Wei Sun
Weng Kung Peng
Ruby Yun-Ju Huang
Jean-Paul Thiery
Roger D Kamm

Funding

Microfluidic 3D Assays for Metastatic CancerR33CA174550 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI KAMM, ROGER D · 2013 to 2015
$1.1M
Microfluidic 3D Scaffold Assay for Cancer Cell Migration and IntravasationR21CA140096 · NCI · CHARLES STARK DRAPER LABORATORY · PI CHAREST, JOSEPH L. · 2009 to 2011
$672k
NCI NIH HHS R21 CA140096NCI NIH HHS R33 CA174550
6 · The paper itself

Abstract

Microwell technology has revolutionized many aspects of in vitro cellular studies from 2D traditional cultures to 3D in vivo-like functional assays. However, existing lithography-based approaches are often costly and time-consuming. This study presents a rapid, low-cost prototyping method of CO2 laser ablation of a conventional untreated culture dish to create concave microwells used for generating multicellular aggregates, which can be readily available for general laboratories. Polymethylmethacrylate (PMMA), polydimethylsiloxane (PDMS), and polystyrene (PS) microwells are investigated, and each produces distinctive microwell features. Among these three materials, PS cell culture dishes produce the optimal surface smoothness and roundness. A549 lung cancer cells are grown to form cancer aggregates of controllable size from ≈40 to ≈80 μm in PS microwells. Functional assays of spheroids are performed to study migration on 2D substrates and in 3D hydrogel conditions as a step towards recapitulating the dissemination of cancer cells. Preclinical anti-cancer drug screening is investigated and reveals considerable differences between 2D and 3D conditions, indicating the importance of assay type as well as the utility of the present approach.

Indexed as

Antineoplastic AgentsCell Culture TechniquesCell Line, TumorCell SurvivalDrug Screening Assays, AntitumorHumansNeoplasmsSpheroids, CellularTumor Cells, CulturedAntineoplastic Agentsdrug screeningmicrowellsmulticellular cancer aggregatesmulticellular spheroids

Identifiers

PMID23983140
PMCPMC4038742

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.